Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 1/2014

01-01-2014 | Literatur kommentiert

Chemo- versus Radiochemotherapie beim nicht-kleinzelligen Bronchialkarzinom im Stadium III mit ungünstigen Prognosefaktoren

Die Conrad-Studie

Author: Prof. Dr. C. Nieder

Published in: Strahlentherapie und Onkologie | Issue 1/2014

Login to get access

Auszug

Strøm HH, Bremnes RM, Sundstrøm SH et al (2013) Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group. Br J Cancer 109:1467–1475 …
Literature
1.
Strøm HH, Bremnes RM, Sundstrøm SH et al (2013) Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group. Br J Cancer 109:1467–1475PubMedCentralPubMedCrossRef
2.
Guckenberger M, Kavanagh A, Partridge M (2012) Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer. Strahlenther Onkol 188:894–900PubMedCrossRef
3.
Nieder C, Pawinski A, Andratschke NH (2013) Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations. Front Oncol 3:176PubMedCentralPubMed
4.
Choy H, Schwartzberg LS, Dakhil SR et al (2013) Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer. J Thorac Oncol (im Druck)
5.
Nawrocki S, Krzakowski M, Wasilewska-Tesluk E et al (2010) Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study. J Thorac Oncol 5:1255–1262PubMedCrossRef
Metadata
Title
Chemo- versus Radiochemotherapie beim nicht-kleinzelligen Bronchialkarzinom im Stadium III mit ungünstigen Prognosefaktoren
Die Conrad-Studie
Author
Prof. Dr. C. Nieder
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 1/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-013-0490-3

Other articles of this Issue 1/2014

Strahlentherapie und Onkologie 1/2014 Go to the issue

Original article

Volumetric evaluation of an alternative bladder point in brachytherapy for locally advanced cervical cancer

Literatur kommentiert

Geringere Akuttoxizität bei Erwachsenen mit Medulloblastom durch kraniospinale Strahlentherapie mit Protonen

Original article

Patterns of care in patients with cervical cancer 2012

Original article

Definition of stereotactic body radiotherapy

Original article

The effect of resveratrol in combination with irradiation and chemotherapy

Original article

Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck